Tobacco product use among middle and high school students National Youth Tobacco Survey, United States, 2024
FDA Commissioner Robert Califf emphasized the long-term impact of the proposal, stating, "By the year 2100, this nicotine product standard could prevent approximately 48 million U.S
Archived from the original on July 17, 2011
At the guideline level: A 2023 Canadian clinical guideline raised concerns that SSRIs may not reliably improve depression in some AUD populations and may worsen alcohol outcomes in certain individuals, recommending caution with SSRIs in that context
Increasingly, growth will have to come from smoke-free products such as ZYN, IQOS, Velo, on!, and newer oral nicotine products offered by smaller competitors